ASCO GU 2019 Africanamerican men with advanced prostate cancer live longer compared with white men when treated with newer hormone therapies

ASCO GU 2019: African-american men with advanced prostate cancer live longer compared with white men when treated with newer hormone therapies

18:00 EST 11 Feb 2019 | ecancermedicalscience

A large, retrospective study analysing five years of data from the Veterans Health Administration (VHA) found that African-American men with metastatic castration-resistant prostate cancer (mCRPC) who were treated with newer prostate cancer drugs -...

More From BioPortfolio on "ASCO GU 2019: African-american men with advanced prostate cancer live longer compared with white men when treated with newer hormone therapies"